[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$2945b

West Pharmaceutical's Q2'25 earnings beat expectations, leading to a raised outlook. The stock is seeing positive engagement on social media platforms.

About $2945b

Analysis of social media engagement and mentions related to the ticker $2945b.

Engagements: X #

Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: X
Daily Average: XXX
1-Year High: XXXXX on 2025-06-27
1-Year Low: X on 2025-05-14

Social Network	X
Engagements	X

Mentions: X #

Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1-Year High: X on 2025-05-13
1-Year Low: X on 2025-05-13

Social Network	X
Mentions	X

Creators: X #

Creators Line Chart
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $2945b in the last XX hours which is no change from in the previous XX hours Daily Average: X
1-Year High: X on 2025-05-13
1-Year Low: X on 2025-05-13

Top topics mentioned In the posts about $2945b in the last XX hours

javascript, $2975b, $306b, $304b

Top Social Posts #

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"$WST West Pharmaceutical Q2'25 Earnings Beat & Raised Outlook 💥 via Revenue: $766.5M (+9.2% YoY) vs. $725.3M est. 🟢 Adj. EPS: $XXXX (+21% YoY) vs. $XXXX est. 🟢 Organic Sales Growth: +6.8% YoY 📈 FY25 Guidance Raised: Revenue: $3.04B$3.06B (Prior: $2.945B$2.975B) EPS: $6.65$6.85 (Est. $6.27) 🟢 Organic Growth: 3%3.75% (Prior: 2%3%) FX Tailwind: +$59M rev / +$0.27 EPS 🧪 Proprietary Products (Q2): Rev: $619.8M (+10.7% YoY) High-Value Components: +11.3% Delivery Devices: +30.0% Standard Products: +0.4% 🏭 Contract-Manufactured Products: Rev: $146.7M (+3.0% YoY) Growth led by self-injection"
@overnight_stock on X 2025-07-24 11:42:05 UTC XXX followers, XX engagements